scispace - formally typeset
T

Tarun Bhatnagar

Researcher at Indian Council of Medical Research

Publications -  74
Citations -  2128

Tarun Bhatnagar is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 16, co-authored 54 publications receiving 1302 citations. Previous affiliations of Tarun Bhatnagar include University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).

TL;DR: This trial has high generalisability and approximates convalescent plasma use in real life settings with limited laboratory capacity and was not associated with a reduction in progression to severe covid-19 or all cause mortality.
Journal ArticleDOI

Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach

TL;DR: Port-of-entry-based entry screening of travellers with suggestive clinical features and from COVID-19-affected countries, would achieve modest delays in the introduction of the virus into the community, however, such measures would be insufficient to delay the outbreak by weeks or longer.
Journal ArticleDOI

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

Manoj V Murhekar, +73 more
TL;DR: Seroprevalence of SARS-CoV-2 was low among the adult population in India around the beginning of May 2020, and males, living in urban slums and occupation with high risk of exposure to potentially infected persons were associated with seropositivity.
Journal ArticleDOI

SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.

Manoj V Murhekar, +107 more
TL;DR: A second household serosurvey among individuals aged 10 years or older in the same 700 villages or wards within 70 districts in India that were included in the first sero-survey was conducted in this article.
Journal ArticleDOI

SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.

TL;DR: A third serosurvey was conducted between December 2020 and January 2021 to estimate the seroprevalence of SARS-CoV-2 infection among the general population and healthcare workers (HCWs) in India as mentioned in this paper.